This week in Cheap Seats: Stocks Under $20 segment, we're taking a look at two stocks that are soaring today: Humacyte Inc (NYSE:HUMA) and American Semiconductor Corp (NASDAQ:AMSC).
Humacyte today announced that it would take part in the Jefferies Global Healthcare Conference. At last glance, HUMA was up 20.5% at $9.29, on track for its best day since August 2023 and trading at its highest levels since December 2021. Since the start of the year, the equity is up roughly 230%.
AMSC is up 14.6% at $18.10, earlier hitting a peak of $20.68, after the chip name's strong first-quarter results. Hitting its highest levels in three years, the security is up 61.7% since the start of 2024.
Options traders are chiming in on the attractively priced stocks. So far today, HUMA has seen 4 times its average daily options volume, with the new positions opening at the most active June 10 call. Traders have targeted AMSC at 14 times its average daily options volume, with new positions opening at the most popular, June 20 call.
It's also worth mentioning that both stocks have a bit of short squeeze potential. Short interest represents 5.2% of HUMA's available float, and 5.4% of AMSC's.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
